世界の筋骨格系障害治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Musculoskeletal Disorders Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z3975 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥565,500 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥848,250 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,131,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、筋骨格系障害治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（OTC、Rx薬）、用途別市場規模（病院、小売薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・筋骨格系障害治療の市場動向 ・企業の競争状況、市場シェア ・筋骨格系障害治療の種類別市場規模（OTC、Rx薬） ・筋骨格系障害治療の用途別市場規模（病院、小売薬局） ・筋骨格系障害治療の北米市場規模2016-2027（アメリカ、カナダ） ・筋骨格系障害治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・筋骨格系障害治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・筋骨格系障害治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・筋骨格系障害治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（AbbVie、Amgen、Johnson & Johnson、Roche、Pfizer Inc、Eli Lilly） ・結論

Musculoskeletal Disorders or MSDs are injuries anddisorders that affect the human body’s movement ormusculoskeletal system (i.e. muscles, tendons, ligaments, nerves, discs, blood vessels, etc.). Common MSDs include: Carpal Tunnel Syndrome. Tendonitis. Muscle / Tendon 

Market Analysis and Insights: Global Musculoskeletal Disorders Treatment Market
The global Musculoskeletal Disorders Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Musculoskeletal Disorders Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Musculoskeletal Disorders Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Musculoskeletal Disorders Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Musculoskeletal Disorders Treatment market.

Global Musculoskeletal Disorders Treatment Scope and Market Size
Musculoskeletal Disorders Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Musculoskeletal Disorders Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
OTC
Rx Drugs

Segment by Application
Hospital
Retail Pharmacy

By Region
North America
the United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
AbbVie
Amgen
Johnson & Johnson
Roche
Pfizer Inc
Eli Lilly

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Musculoskeletal Disorders Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 OTC
1.2.3 Rx Drugs
1.3 Market by Application
1.3.1 Global Musculoskeletal Disorders Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Musculoskeletal Disorders Treatment Market Perspective (2016-2027)
2.2 Musculoskeletal Disorders Treatment Growth Trends by Regions
2.2.1 Musculoskeletal Disorders Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Musculoskeletal Disorders Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Musculoskeletal Disorders Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Musculoskeletal Disorders Treatment Industry Dynamic
2.3.1 Musculoskeletal Disorders Treatment Market Trends
2.3.2 Musculoskeletal Disorders Treatment Market Drivers
2.3.3 Musculoskeletal Disorders Treatment Market Challenges
2.3.4 Musculoskeletal Disorders Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Musculoskeletal Disorders Treatment Players by Revenue
3.1.1 Global Top Musculoskeletal Disorders Treatment Players by Revenue (2016-2021)
3.1.2 Global Musculoskeletal Disorders Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Musculoskeletal Disorders Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Musculoskeletal Disorders Treatment Revenue
3.4 Global Musculoskeletal Disorders Treatment Market Concentration Ratio
3.4.1 Global Musculoskeletal Disorders Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Musculoskeletal Disorders Treatment Revenue in 2020
3.5 Musculoskeletal Disorders Treatment Key Players Head office and Area Served
3.6 Key Players Musculoskeletal Disorders Treatment Product Solution and Service
3.7 Date of Enter into Musculoskeletal Disorders Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Musculoskeletal Disorders Treatment Breakdown Data by Type
4.1 Global Musculoskeletal Disorders Treatment Historic Market Size by Type (2016-2021)
4.2 Global Musculoskeletal Disorders Treatment Forecasted Market Size by Type (2022-2027)

5 Musculoskeletal Disorders Treatment Breakdown Data by Application
5.1 Global Musculoskeletal Disorders Treatment Historic Market Size by Application (2016-2021)
5.2 Global Musculoskeletal Disorders Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Musculoskeletal Disorders Treatment Market Size (2016-2027)
6.2 North America Musculoskeletal Disorders Treatment Market Size by Type
6.2.1 North America Musculoskeletal Disorders Treatment Market Size by Type (2016-2021)
6.2.2 North America Musculoskeletal Disorders Treatment Market Size by Type (2022-2027)
6.2.3 North America Musculoskeletal Disorders Treatment Market Size by Type (2016-2027)
6.3 North America Musculoskeletal Disorders Treatment Market Size by Application
6.3.1 North America Musculoskeletal Disorders Treatment Market Size by Application (2016-2021)
6.3.2 North America Musculoskeletal Disorders Treatment Market Size by Application (2022-2027)
6.3.3 North America Musculoskeletal Disorders Treatment Market Size by Application (2016-2027)
6.4 North America Musculoskeletal Disorders Treatment Market Size by Country
6.4.1 North America Musculoskeletal Disorders Treatment Market Size by Country (2016-2021)
6.4.2 North America Musculoskeletal Disorders Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Musculoskeletal Disorders Treatment Market Size (2016-2027)
7.2 Europe Musculoskeletal Disorders Treatment Market Size by Type
7.2.1 Europe Musculoskeletal Disorders Treatment Market Size by Type (2016-2021)
7.2.2 Europe Musculoskeletal Disorders Treatment Market Size by Type (2022-2027)
7.2.3 Europe Musculoskeletal Disorders Treatment Market Size by Type (2016-2027)
7.3 Europe Musculoskeletal Disorders Treatment Market Size by Application
7.3.1 Europe Musculoskeletal Disorders Treatment Market Size by Application (2016-2021)
7.3.2 Europe Musculoskeletal Disorders Treatment Market Size by Application (2022-2027)
7.3.3 Europe Musculoskeletal Disorders Treatment Market Size by Application (2016-2027)
7.4 Europe Musculoskeletal Disorders Treatment Market Size by Country
7.4.1 Europe Musculoskeletal Disorders Treatment Market Size by Country (2016-2021)
7.4.2 Europe Musculoskeletal Disorders Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Musculoskeletal Disorders Treatment Market Size (2016-2027)
8.2 Asia-Pacific Musculoskeletal Disorders Treatment Market Size by Type
8.2.1 Asia-Pacific Musculoskeletal Disorders Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Musculoskeletal Disorders Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Musculoskeletal Disorders Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Musculoskeletal Disorders Treatment Market Size by Application
8.3.1 Asia-Pacific Musculoskeletal Disorders Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Musculoskeletal Disorders Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Musculoskeletal Disorders Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Musculoskeletal Disorders Treatment Market Size by Region
8.4.1 Asia-Pacific Musculoskeletal Disorders Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Musculoskeletal Disorders Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Musculoskeletal Disorders Treatment Market Size (2016-2027)
9.2 Latin America Musculoskeletal Disorders Treatment Market Size by Type
9.2.1 Latin America Musculoskeletal Disorders Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Musculoskeletal Disorders Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Musculoskeletal Disorders Treatment Market Size by Type (2016-2027)
9.3 Latin America Musculoskeletal Disorders Treatment Market Size by Application
9.3.1 Latin America Musculoskeletal Disorders Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Musculoskeletal Disorders Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Musculoskeletal Disorders Treatment Market Size by Application (2016-2027)
9.4 Latin America Musculoskeletal Disorders Treatment Market Size by Country
9.4.1 Latin America Musculoskeletal Disorders Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Musculoskeletal Disorders Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Musculoskeletal Disorders Treatment Market Size (2016-2027)
10.2 Middle East & Africa Musculoskeletal Disorders Treatment Market Size by Type
10.2.1 Middle East & Africa Musculoskeletal Disorders Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Musculoskeletal Disorders Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Musculoskeletal Disorders Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Musculoskeletal Disorders Treatment Market Size by Application
10.3.1 Middle East & Africa Musculoskeletal Disorders Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Musculoskeletal Disorders Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Musculoskeletal Disorders Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Musculoskeletal Disorders Treatment Market Size by Country
10.4.1 Middle East & Africa Musculoskeletal Disorders Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Musculoskeletal Disorders Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 AbbVie
11.1.1 AbbVie Company Details
11.1.2 AbbVie Business Overview
11.1.3 AbbVie Musculoskeletal Disorders Treatment Introduction
11.1.4 AbbVie Revenue in Musculoskeletal Disorders Treatment Business (2016-2021)
11.1.5 AbbVie Recent Development
11.2 Amgen
11.2.1 Amgen Company Details
11.2.2 Amgen Business Overview
11.2.3 Amgen Musculoskeletal Disorders Treatment Introduction
11.2.4 Amgen Revenue in Musculoskeletal Disorders Treatment Business (2016-2021)
11.2.5 Amgen Recent Development
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Details
11.3.2 Johnson & Johnson Business Overview
11.3.3 Johnson & Johnson Musculoskeletal Disorders Treatment Introduction
11.3.4 Johnson & Johnson Revenue in Musculoskeletal Disorders Treatment Business (2016-2021)
11.3.5 Johnson & Johnson Recent Development
11.4 Roche
11.4.1 Roche Company Details
11.4.2 Roche Business Overview
11.4.3 Roche Musculoskeletal Disorders Treatment Introduction
11.4.4 Roche Revenue in Musculoskeletal Disorders Treatment Business (2016-2021)
11.4.5 Roche Recent Development
11.5 Pfizer Inc
11.5.1 Pfizer Inc Company Details
11.5.2 Pfizer Inc Business Overview
11.5.3 Pfizer Inc Musculoskeletal Disorders Treatment Introduction
11.5.4 Pfizer Inc Revenue in Musculoskeletal Disorders Treatment Business (2016-2021)
11.5.5 Pfizer Inc Recent Development
11.6 Eli Lilly
11.6.1 Eli Lilly Company Details
11.6.2 Eli Lilly Business Overview
11.6.3 Eli Lilly Musculoskeletal Disorders Treatment Introduction
11.6.4 Eli Lilly Revenue in Musculoskeletal Disorders Treatment Business (2016-2021)
11.6.5 Eli Lilly Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Musculoskeletal Disorders Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of OTC
Table 3. Key Players of Rx Drugs
Table 4. Global Musculoskeletal Disorders Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Musculoskeletal Disorders Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Musculoskeletal Disorders Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Musculoskeletal Disorders Treatment Market Share by Regions (2016-2021)
Table 8. Global Musculoskeletal Disorders Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Musculoskeletal Disorders Treatment Market Share by Regions (2022-2027)
Table 10. Musculoskeletal Disorders Treatment Market Trends
Table 11. Musculoskeletal Disorders Treatment Market Drivers
Table 12. Musculoskeletal Disorders Treatment Market Challenges
Table 13. Musculoskeletal Disorders Treatment Market Restraints
Table 14. Global Musculoskeletal Disorders Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Musculoskeletal Disorders Treatment Market Share by Players (2016-2021)
Table 16. Global Top Musculoskeletal Disorders Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Musculoskeletal Disorders Treatment as of 2020)
Table 17. Ranking of Global Top Musculoskeletal Disorders Treatment Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Musculoskeletal Disorders Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Musculoskeletal Disorders Treatment Product Solution and Service
Table 21. Date of Enter into Musculoskeletal Disorders Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Musculoskeletal Disorders Treatment Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Musculoskeletal Disorders Treatment Revenue Market Share by Type (2016-2021)
Table 25. Global Musculoskeletal Disorders Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Musculoskeletal Disorders Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Musculoskeletal Disorders Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Musculoskeletal Disorders Treatment Revenue Market Share by Application (2016-2021)
Table 29. Global Musculoskeletal Disorders Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Musculoskeletal Disorders Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Musculoskeletal Disorders Treatment Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Musculoskeletal Disorders Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Musculoskeletal Disorders Treatment Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Musculoskeletal Disorders Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Musculoskeletal Disorders Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Musculoskeletal Disorders Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Musculoskeletal Disorders Treatment Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Musculoskeletal Disorders Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Musculoskeletal Disorders Treatment Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Musculoskeletal Disorders Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Musculoskeletal Disorders Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Musculoskeletal Disorders Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Musculoskeletal Disorders Treatment Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Musculoskeletal Disorders Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Musculoskeletal Disorders Treatment Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Musculoskeletal Disorders Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Musculoskeletal Disorders Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Musculoskeletal Disorders Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Musculoskeletal Disorders Treatment Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Musculoskeletal Disorders Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Musculoskeletal Disorders Treatment Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Musculoskeletal Disorders Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Musculoskeletal Disorders Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Musculoskeletal Disorders Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Musculoskeletal Disorders Treatment Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Musculoskeletal Disorders Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Musculoskeletal Disorders Treatment Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Musculoskeletal Disorders Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Musculoskeletal Disorders Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Musculoskeletal Disorders Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 61. AbbVie Company Details
Table 62. AbbVie Business Overview
Table 63. AbbVie Musculoskeletal Disorders Treatment Product
Table 64. AbbVie Revenue in Musculoskeletal Disorders Treatment Business (2016-2021) & (US$ Million)
Table 65. AbbVie Recent Development
Table 66. Amgen Company Details
Table 67. Amgen Business Overview
Table 68. Amgen Musculoskeletal Disorders Treatment Product
Table 69. Amgen Revenue in Musculoskeletal Disorders Treatment Business (2016-2021) & (US$ Million)
Table 70. Amgen Recent Development
Table 71. Johnson & Johnson Company Details
Table 72. Johnson & Johnson Business Overview
Table 73. Johnson & Johnson Musculoskeletal Disorders Treatment Product
Table 74. Johnson & Johnson Revenue in Musculoskeletal Disorders Treatment Business (2016-2021) & (US$ Million)
Table 75. Johnson & Johnson Recent Development
Table 76. Roche Company Details
Table 77. Roche Business Overview
Table 78. Roche Musculoskeletal Disorders Treatment Product
Table 79. Roche Revenue in Musculoskeletal Disorders Treatment Business (2016-2021) & (US$ Million)
Table 80. Roche Recent Development
Table 81. Pfizer Inc Company Details
Table 82. Pfizer Inc Business Overview
Table 83. Pfizer Inc Musculoskeletal Disorders Treatment Product
Table 84. Pfizer Inc Revenue in Musculoskeletal Disorders Treatment Business (2016-2021) & (US$ Million)
Table 85. Pfizer Inc Recent Development
Table 86. Eli Lilly Company Details
Table 87. Eli Lilly Business Overview
Table 88. Eli Lilly Musculoskeletal Disorders Treatment Product
Table 89. Eli Lilly Revenue in Musculoskeletal Disorders Treatment Business (2016-2021) & (US$ Million)
Table 90. Eli Lilly Recent Development
Table 91. Research Programs/Design for This Report
Table 92. Key Data Information from Secondary Sources
Table 93. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Musculoskeletal Disorders Treatment Market Share by Type: 2020 VS 2027
Figure 2. OTC Features
Figure 3. Rx Drugs Features
Figure 4. Global Musculoskeletal Disorders Treatment Market Share by Application: 2020 VS 2027
Figure 5. Hospital Case Studies
Figure 6. Retail Pharmacy Case Studies
Figure 7. Musculoskeletal Disorders Treatment Report Years Considered
Figure 8. Global Musculoskeletal Disorders Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 9. Global Musculoskeletal Disorders Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Musculoskeletal Disorders Treatment Market Share by Regions: 2020 VS 2027
Figure 11. Global Musculoskeletal Disorders Treatment Market Share by Regions (2022-2027)
Figure 12. Global Musculoskeletal Disorders Treatment Market Share by Players in 2020
Figure 13. Global Top Musculoskeletal Disorders Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Musculoskeletal Disorders Treatment as of 2020
Figure 14. The Top 10 and 5 Players Market Share by Musculoskeletal Disorders Treatment Revenue in 2020
Figure 15. Global Musculoskeletal Disorders Treatment Revenue Market Share by Type (2016-2021)
Figure 16. Global Musculoskeletal Disorders Treatment Revenue Market Share by Type (2022-2027)
Figure 17. North America Musculoskeletal Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 18. North America Musculoskeletal Disorders Treatment Market Share by Type (2016-2027)
Figure 19. North America Musculoskeletal Disorders Treatment Market Share by Application (2016-2027)
Figure 20. North America Musculoskeletal Disorders Treatment Market Share by Country (2016-2027)
Figure 21. United States Musculoskeletal Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. Canada Musculoskeletal Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Europe Musculoskeletal Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Musculoskeletal Disorders Treatment Market Share by Type (2016-2027)
Figure 25. Europe Musculoskeletal Disorders Treatment Market Share by Application (2016-2027)
Figure 26. Europe Musculoskeletal Disorders Treatment Market Share by Country (2016-2027)
Figure 27. Germany Musculoskeletal Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. France Musculoskeletal Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. U.K. Musculoskeletal Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Italy Musculoskeletal Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Russia Musculoskeletal Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Nordic Musculoskeletal Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Asia-Pacific Musculoskeletal Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Musculoskeletal Disorders Treatment Market Share by Type (2016-2027)
Figure 35. Asia-Pacific Musculoskeletal Disorders Treatment Market Share by Application (2016-2027)
Figure 36. Asia-Pacific Musculoskeletal Disorders Treatment Market Share by Region (2016-2027)
Figure 37. China Musculoskeletal Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Japan Musculoskeletal Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. South Korea Musculoskeletal Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Southeast Asia Musculoskeletal Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. India Musculoskeletal Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Australia Musculoskeletal Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Latin America Musculoskeletal Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Musculoskeletal Disorders Treatment Market Share by Type (2016-2027)
Figure 45. Latin America Musculoskeletal Disorders Treatment Market Share by Application (2016-2027)
Figure 46. Latin America Musculoskeletal Disorders Treatment Market Share by Country (2016-2027)
Figure 47. Mexico Musculoskeletal Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Brazil Musculoskeletal Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Middle East & Africa Musculoskeletal Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Musculoskeletal Disorders Treatment Market Share by Type (2016-2027)
Figure 51. Middle East & Africa Musculoskeletal Disorders Treatment Market Share by Application (2016-2027)
Figure 52. Middle East & Africa Musculoskeletal Disorders Treatment Market Share by Country (2016-2027)
Figure 53. Turkey Musculoskeletal Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Saudi Arabia Musculoskeletal Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. UAE Musculoskeletal Disorders Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. AbbVie Revenue Growth Rate in Musculoskeletal Disorders Treatment Business (2016-2021)
Figure 57. Amgen Revenue Growth Rate in Musculoskeletal Disorders Treatment Business (2016-2021)
Figure 58. Johnson & Johnson Revenue Growth Rate in Musculoskeletal Disorders Treatment Business (2016-2021)
Figure 59. Roche Revenue Growth Rate in Musculoskeletal Disorders Treatment Business (2016-2021)
Figure 60. Pfizer Inc Revenue Growth Rate in Musculoskeletal Disorders Treatment Business (2016-2021)
Figure 61. Eli Lilly Revenue Growth Rate in Musculoskeletal Disorders Treatment Business (2016-2021)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed

---